India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
INDIA’S FIRST ALZHEIMER’S DISEASE-MODIFYING THERAPY Why in the News? Drug Launch: Eli Lilly launched donanemab in India under the brand name Lormalzi for Alzheimer’s treatment. First Therapy: It is the first Alzheimer’s disease-modifying therapy commercially launched in India for early-stage patients. High Cost: The treatment costs around ₹91,688 per dose and requires monthly infusions for …
Read MoreCAR-T CELL THERAPY BREAKTHROUGH IN SOLID TUMOURS Why in the News? Scientists have developed a highly sensitive receptor (HIT receptor) that enables CAR-T cells to detect low-level tumour proteins. The breakthrough could make CAR-T therapy effective against solid cancers like kidney and ovarian cancer, overcoming a long-standing limitation. Key scientific advancement Concept innovation: Uses an …
Read MoreICMR Develops Promising New Malaria Vaccine Candidate Why in the News? The Indian Council of Medical Research (ICMR) has unveiled AdFalciVax, a potential malaria vaccine candidate offering over 90% protection in mice, with plans for further development and clinical trials, raising fresh hopes in the decades-long global malaria fight. AdFalciVax: A Breakthrough Against Malaria: AdFalciVax …
Read MoreWhy in the News ? Scientists from Tata Memorial Centre have developed patient-derived organoid and xenograft models to study Signet Ring Cell Carcinoma (SRCC), a rare and aggressive colorectal cancer. This breakthrough could enable targeted therapies and improve treatment outcomes for SRCC patients. New Breakthrough in Rare Colorectal Cancer Research: Scientists have devised advanced methods …
Read MoreWhy in News ? Scientists have identified BbLDH, an enzyme critical for the survival of Borrelia burgdorferi, the bacteria causing Lyme disease. This discovery could lead to new targeted treatments or vaccines, offering hope for better disease management and prevention. Causes and Transmission: Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted through the …
Read MoreWhy in the news? “IISc develops synthetic compounds to target cancer cells, utilising serum albumin for efficient delivery, promising advancements in vaccine development.” source:midine About the IISc Breakthrough in Cancer Vaccine Development: Indian Institute of Science (IISc) researchers develop a synthetic compound (antigen) to target cancer cells effectively. The compound is designed to bind to …
Read More
